SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-150688
Filing Date
2021-05-05
Accepted
2021-05-05 06:06:01
Documents
12
Period of Report
2021-05-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d158302d8k.htm   iXBRL 8-K 22640
  Complete submission text file 0001193125-21-150688.txt   144491

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnov-20210505.xsd EX-101.SCH 3075
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20210505_lab.xml EX-101.LAB 18138
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20210505_pre.xml EX-101.PRE 11411
5 EXTRACTED XBRL INSTANCE DOCUMENT d158302d8k_htm.xml XML 3390
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33185 | Film No.: 21891018
SIC: 2834 Pharmaceutical Preparations